Health and Human Services News and Research

RSS

Study reveals how people respond to financial and health uncertainties

A recent qualitative study sheds light on how people cope with health and financial challenges, highlighting the important role that communication plays in these coping strategies.

16 Feb 2021

New analysis shows that surgeon scientists have become more diverse in their research efforts

An analysis of the National Institutes of Health database reveals surgeon scientists have become more diverse in their research efforts, while still keeping a focus on basic science.

15 Feb 2021

Humidity created inside the face masks may help combat COVID-19

Masks help protect the people wearing them from getting or spreading SARS-CoV-2, the virus that causes COVID-19, but now researchers from the National Institutes of Health have added evidence for yet another potential benefit for wearers: The humidity created inside the mask may help combat respiratory diseases such as COVID-19.

14 Feb 2021

In search of the shot

Too little covid vaccine and too great a demand: That's what KHN readers from around the country detail in their often exasperating quest to snag a shot, although they are often clearly eligible under their local guidelines and priority system.

13 Feb 2021

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer.

13 Feb 2021

Study finds early risk factors for heightened anxiety in young adults during COVID-19

A new study has identified early risk factors that predicted heightened anxiety in young adults during the coronavirus (COVID-19) pandemic.

12 Feb 2021

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19.

10 Feb 2021

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

Researchers at University of Illinois Chicago have been awarded a five-year, $10.15 million grant to develop a broad-spectrum immunomodulatory eye drop to treat patients with severe dry eye and ocular surface disease due to inflammatory and immune system disorders.

9 Feb 2021

Differences in gene readouts may shed light on mental disorders

A new study suggests that differences in the expression of gene transcripts - readouts copied from DNA that help maintain and build our cells - may hold the key to understanding how mental disorders with shared genetic risk factors result in different patterns of onset, symptoms, course of illness, and treatment responses

8 Feb 2021

FDA permits marketing of new prescription only device to reduce snoring and mild sleep apnea

Today, the U.S. Food and Drug Administration authorized marketing of a new prescription only device intended to reduce snoring and mild obstructive sleep apnea.

5 Feb 2021

$FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma$

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.

5 Feb 2021

The state of vaccine supply: ‘Opaque.’ Unpredictable. ‘Hard to pin down.’

Even as the pace of vaccination against covid-19 has steadily accelerated — hitting an average of 1.3 million doses a day in the last days of January — the frustration felt by many of those unable to secure an appointment hasn't waned.

5 Feb 2021

FDA schedules meeting to discuss EUA request for Janssen’s COVID-19 vaccine

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Janssen Biotech Inc.

5 Feb 2021

Health and Human Services News and Research

Study reveals how people respond to financial and health uncertainties

New analysis shows that surgeon scientists have become more diverse in their research efforts

Humidity created inside the face masks may help combat COVID-19

In search of the shot

FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression

Study finds early risk factors for heightened anxiety in young adults during COVID-19

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

UIC researchers receive $10.15 million grant to develop treatment for dry eye conditions

Differences in gene readouts may shed light on mental disorders

FDA permits marketing of new prescription only device to reduce snoring and mild sleep apnea

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

The state of vaccine supply: ‘Opaque.’ Unpredictable. ‘Hard to pin down.’

FDA schedules meeting to discuss EUA request for Janssen’s COVID-19 vaccine

FDA continues to support the development of medical products to tackle new virus variants

CHiPS program reduces unwanted sexual contact among U.S. Air Force cadets

Study: Remote supervision could expand access to neurointerventional technologies

New computerized adaptive screener may help identify youth at risk for attempting suicide

Experimental intranasal influenza vaccine produces durable immune response

College women who experienced period poverty are more vulnerable to depression

Inhaling unfragmented hyaluronan improves lung function in COPD patients

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News